Metformin reduces overall cancer risk in patients with Type 2 diabetes

Links shared publicly online about this topic.

  • 0
    total visits

Metformin reduces overall cancer risk in patients with Type 2 diabetes

news-medical.net

A commonly prescribed diabetes drug, metformin, reduces the overall cancer risk in people with Type 2 diabetes, a large systematic review study finds. The results will be presented Monday at The Endocrine Society's 94th Annual Meeting in Houston.

View full resource at news-medical.net

Tags:

  • Share

Most Recently Shared on June 26, 2012 at 2:18 pm By:

BreastCancers News-Medical.Net

Breast Cancer News: Metformin reduces overall cancer risk in patients with Type 2 diabetes: A commonly prescribe... http://t.co/opZUPBJN

2 days ago...

Also Shared By:

News-Medical.Net News-Medical.Net

New Study Shows Metformin Therapy May Reduce Risk of Colon Cancer in Diabetics, as Reported by DiabeticLive.com

prweb.com — “A research team at the Shanghai Jiao Tong University in China has conducted a meta-analysis demonstrating that metformin treatment also appears to be associated with significantly lower risk of colorectal cancer in patients with type 2 diabetes as reported by DiabeticLive.com.View full resource at prweb.com

  • View Related
  • Share

Most Recently Shared on October 14, 2011 at 3:25 pm By:

diabeticlive diabeticlive Health Site

Metformin Therapy May Reduce Risk of Colon Cancer in Diabetics http://t.co/uuSRlJBi

8 months ago...

Meta-analysis: Metformin may reduce colon cancer risk in type 2 diabetes

endocrinetoday.com — “Treatment with metformin has been associated with a significantly lower risk for cancer cell growth, thereby reducing the risk for cancer overall.View full resource at endocrinetoday.com

  • View Related
  • Share

Most Recently Shared on October 12, 2011 at 1:53 pm By:

Metformin and the Incidence of Prostate Cancer in Patients with Type 2 Diabetes --" Cancer Epidemiol Biomarkers Prev

cebp.aacrjournals.org — “Metformin and the Incidence of Prostate Cancer in Patients with Type 2 Diabetes --" Cancer Epidemiol Biomarkers PrevView full resource at cebp.aacrjournals.org

  • View Related
  • Share

Most Recently Shared on February 10, 2011 at 7:29 pm By:

ysijp Yvo Sijpkens MD Physician, Doctor, Internist, and Nephrologist

Metformin does not reduce the risk of prostate cancer in patients with type 2 #diabetes: http://bit.ly/dGwhMT

1 year ago...

Metformin Protects Against Cancer in Type 2 Diabetes

cme.medscape.com — “: An epidemiologic study has shown that metformin reduces the risk for pancreatic and colon cancers in patients with type 2 diabetes.View full resource at cme.medscape.com

  • View Related
  • Share

Most Recently Shared on October 18, 2009 at 1:12 am By:

palmdoc Alan Teh Hematologist, Physician, Doctor, and Medical Technology

Metformin was found to reduce risk in pancreatic and colon cancers in patients with type 2 diabetes http://is.gd/4on1L

3 years ago...

Metformin lowered risk for cancer in people with type 2 diabetes

endocrinetoday.com — “Researchers in the United Kingdom reported that metformin reduced the risk for cancer in patients with type 2 diabetes when compared with patienView full resource at endocrinetoday.com

  • View Related
  • Share

Most Recently Shared on September 23, 2009 at 3:16 pm By:

EndocrineToday Endocrine Today Health News

Study: Metformin lowered risk for #cancer in people with type 2 #diabetes http://ow.ly/qMVc

3 years ago...

Advertisement